Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026)
Opko Health (OPK) posted Total Non-Current Liabilities of $503.8 million for Q1 2026, down 2.61% quarter-over-quarter from $517.3 million in Q4 2025, and down 3.27% year-on-year from $520.8 million in Q1 2025.
Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Total Non-Current Liabilities for 17 consecutive years, with $503.8 million the latest figure, recorded in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $503.8 million, down 3.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $503.8 million (down 3.27% YoY), and the FY2025 annual result was $517.3 million, down 19.38% from the prior year.
- Total Non-Current Liabilities was $503.8 million for Q1 2026 at Opko Health, down from $517.3 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $641.7 million in Q4 2024 and troughed at $328.4 million in Q3 2022.
- Average Total Non-Current Liabilities over 5 years is $464.5 million, with a median of $435.3 million recorded in 2022.
- Year-over-year, Total Non-Current Liabilities jumped 55.76% in 2024 and fell 19.38% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $392.1 million in 2022, then rose by 7.73% to $422.4 million in 2023, then jumped by 51.9% to $641.7 million in 2024, then decreased by 19.38% to $517.3 million in 2025, then dropped by 2.61% to $503.8 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $503.8 million in Q1 2026, $517.3 million in Q4 2025, and $520.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Opko Health | 1.16 Bn | 819.20 Mn | 45.76 Mn | 503.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503.80 Mn |
| Dec 31, 2025 | 517.31 Mn |
| Sep 30, 2025 | 520.70 Mn |
| Jun 30, 2025 | 504.90 Mn |
| Mar 31, 2025 | 520.81 Mn |
| Dec 31, 2024 | 641.67 Mn |
| Sep 30, 2024 | 641.03 Mn |
| Jun 30, 2024 | 365.00 Mn |
| Mar 31, 2024 | 516.87 Mn |
| Dec 31, 2023 | 422.43 Mn |
| Sep 30, 2023 | 411.56 Mn |
| Jun 30, 2023 | 397.10 Mn |
| Mar 31, 2023 | 395.44 Mn |
| Dec 31, 2022 | 392.13 Mn |
| Sep 30, 2022 | 328.45 Mn |
| Jun 30, 2022 | 435.33 Mn |
| Mar 31, 2022 | 382.80 Mn |
| Dec 31, 2021 | 384.58 Mn |
| Sep 30, 2021 | 369.04 Mn |
| Jun 30, 2021 | 375.09 Mn |